Trial intelligence / Profile preview

Gleevec and Vectibix in metastatic colorectal cancer

NCT00867334Phase 2Completed

Sponsor
Inova Health System
Start
Jun 2009
Primary completion
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of imatinib in colorectal cancer (CRC), sponsored by Inova Health System. Started Jun 2009; status: completed.

02

Drugs

03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00867334.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00867334.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call